Heme oxygenase-1 and inflammation in experimental right ventricular failure on prolonged overcirculation-induced pulmonary hypertension

PLoS One. 2013 Jul 25;8(7):e69470. doi: 10.1371/journal.pone.0069470. Print 2013.

Abstract

Heme oxygenase (HO)-1 is a stress response enzyme which presents with cardiovascular protective and anti-inflammatory properties. Six-month chronic overcirculation-induced pulmonary arterial hypertension (PAH) in piglets has been previously reported as a model of right ventricular (RV) failure related to the RV activation of apoptotic and inflammatory processes. We hypothesized that altered HO-1 signalling could be involved in both pulmonary vascular and RV changes. Fifteen growing piglets were assigned to a sham operation (n = 8) or to an anastomosis of the left innominate artery to the pulmonary arterial trunk (n = 7). Six months later, hemodynamics was evaluated after closure of the shunt. After euthanasia of the animals, pulmonary and myocardial tissue was sampled for pathobiological evaluation. Prolonged shunting was associated with a tendency to decreased pulmonary gene and protein expressions of HO-1, while pulmonary gene expressions of interleukin (IL)-33, IL-19, intercellular adhesion molecule (ICAM)-1 and -2 were increased. Pulmonary expressions of constitutive HO-2 and pro-inflammatory tumor necrosis factor (TNF)-α remained unchanged. Pulmonary vascular resistance (evaluated by pressure/flow plots) was inversely correlated to pulmonary HO-1 protein and IL-19 gene expressions, and correlated to pulmonary ICAM-1 gene expression. Pulmonary arteriolar medial thickness and PVR were inversely correlated to pulmonary IL-19 expression. RV expression of HO-1 was decreased, while RV gene expressions TNF-α and ICAM-2 were increased. There was a correlation between RV ratio of end-systolic to pulmonary arterial elastances and RV HO-1 expression. These results suggest that downregulation of HO-1 is associated to PAH and RV failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD / genetics
  • Antigens, CD / immunology
  • Disease Models, Animal
  • Down-Regulation
  • Familial Primary Pulmonary Hypertension
  • Gene Expression
  • Heme Oxygenase-1 / genetics*
  • Heme Oxygenase-1 / immunology
  • Hemodynamics
  • Hypertension, Pulmonary / complications
  • Hypertension, Pulmonary / genetics*
  • Hypertension, Pulmonary / immunology
  • Hypertension, Pulmonary / physiopathology
  • Inflammation / complications
  • Inflammation / genetics
  • Inflammation / immunology
  • Inflammation / physiopathology
  • Intercellular Adhesion Molecule-1 / genetics
  • Intercellular Adhesion Molecule-1 / immunology
  • Interleukins / genetics
  • Interleukins / immunology
  • Signal Transduction
  • Swine
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / immunology
  • Ventricular Dysfunction, Right / complications
  • Ventricular Dysfunction, Right / genetics*
  • Ventricular Dysfunction, Right / immunology
  • Ventricular Dysfunction, Right / physiopathology

Substances

  • Antigens, CD
  • Interleukins
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
  • Heme Oxygenase-1

Grants and funding

This work was supported by grants from the “Fonds de la Recherche Scientifique Medicale FNRS)” (grant number 3.4637.09) and the Belgian Foundation for Cardiac Surgery. C.D. was supported by the Erasmus Foundation (Belgium) and is a FNRS doctoral fellow (“Aspirant FNRS”; Belgium). L.D. was supported by a Pfizer research grant and is a FNRS postdoctoral fellow (“Chargé de Recherches”; Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.